Schedule dependency of paclitaxel-induced neuropathy in mice: A morphological study

NeuroToxicology

Volumn 21, Issue 4, 2000, Pages 513-520

  Mimura, Y ^a   Kato, H ^a   Eguchi, K ^a   Ogawa, T ^a  

^a Grelan Pharmaceutical Co Ltd   (Japan)

Author keywords

Mice; Neuropathological study; Paclitaxel; Peripheral neuropathy; Schedule dependency

Indexed keywords

TAXOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; MALE; MOUSE; NERVE CELL DEGENERATION; NERVE CONDUCTION; NERVE FIBER; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSORY NEUROPATHY;

ACTION POTENTIALS; ANIMAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BEHAVIOR, ANIMAL; BODY WEIGHT; ELECTROPHYSIOLOGY; GANGLIA, SPINAL; INJECTIONS, INTRAPERITONEAL; MALE; MICE; NERVE DEGENERATION; NERVE FIBERS; NEUROPEPTIDES; NEUROTOXICITY SYNDROMES; PACLITAXEL; PAIN THRESHOLD; SCIATIC NERVE;

EID: 0033789522     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Characterization of pasttranslational modifications in neuron-specific class III β-tubulin by mass spectrometry
2. Differential effects of microtuble inhibitions on axonal branching and elongation of cultured rat hippocampal neurons
3. Nerve Growth factor prevents toxic neuropathy in mice
4. Current dosage and schedule issues in the development of paclitaxel (Taxol®)
5. The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies
6. Prosaptide prevents paclitaxel neurotoxicity
7. Clinical neurotoxic concerns on antineoplastic agents
8. Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat
9. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol
10. Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat
11. Influence of mulnutrition on developing rat peripheral nerves
12. Phase I trial of taxol in patients with advanced cancer
13. Calibers and microtubules of nerve fibers: Differential effect of undernutrition in developing and adult rats
14. Peripheral neurotoxicity induced by docetaxel
15. Neuropathological changes and neurological function after spinal cord compression in the rat
16. Vincristine neurotoxicity. Pathophysiology and management
17. Phase I study of taxol using a 5-day intermittent schedule
18. Inhibition of neurite initiation and growth by taxol
19. Branching of sensory and sympathetic neurites in vitro is inhibited by treatment with taxol
20. Five mouse tubulin isotypes and their regulated expression during development
21. Taxol produces a predominantly sensory neuropathy
22. Vincristine neuropathy: An electrophysiological and histological study
23. Expression of the class III β-tubulin gene during axonal regeneration of rat dorsal root ganglion neurons
24. A simple and rapid test of sensorimotor function in the aged rat
25. Peripheral neuropathy secondary to docetaxel (Taxotere)
26. Paclitaxel-induced neuropathy
27. Corticosteroid co-medication does not reduce the incidence and severity of neurotoxicity induced by docetaxel
28. Objective clinical assessment of motor function after experimental apinal cord injury in the rat
29. Taxol: A review of its preclinical in vivo antitumor activity
30. Taxol-based combination chemotherapy and other in vivo preclinical antitumor studies
31. Phase I and pharmacodynamic study of taxol in refractory acute leukemias
32. Taxol: A novel investigational antimicrotubule agent
33. Taxol neuropathy. Electrodiagnostic and sural nerve biopsy fnding
34. Evaluation of brain and nerve pathology in rats chronically dosed with ddI or isoniazide
35. Promotion of microtuble assembly in vitro by taxol
36. Six mouse α-tubulin mRNAs encode five distnct isotypes: Testis-specific expression of two sister genes
37. The acute response of schwann cells to taxol after nerve crush
38. The acute response of schwann cells to taxol after nerve crush
39. The mammalian β-tubulin repertoire: Hematopoietic expression of a novel, heterogous β-tubulin isotype
40. Phase I trial of taxol given as a 24-hour infusion every 21 days: Responses observed in metastatic melanoma
41. Phase I clinical and pharmacokinetic study of taxol
42. Motor nerve conduction velocities during growth of SD rats fed ad libitum or restricted diets